Primary Record
neostigmine bromide
- In stock
- 5,474 g
- Purity
- 98.2 %
- CAS
- 114-80-7
Compound Identifiers & Properties
- CAS
- 114-80-7
- PubChem CID
- 8246
- SMILES
- CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-]
- Canonical SMILES
- CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]
Names & Synonyms
- neostigmine bromide
- Vagostigmin
- 114-80-7
- Eustigmin bromide
- Neoserine bromide
- neo-Proserin
- Prostigmin
- Kirkstigmine bromide
- Proserine bromide
- Stigmanol bromide
- Neo proserine
- Synstigmin bromide
- Neoproserine
- Syntostigmin bromide
- Leostigmine bromide
- Neostigmini bromidum
- Philostigmin bromide
- Stigmosan bromide
- Synstigminbromid
- Prostigmin bromide
- Bromure de neostigmine
- Bromuro de neostigmina
- bromide
- Prostigmine bromide
- Juvastigmin
- Neoesserin
- Neostigmin
- Prostigmine
- stigmanolbromide
- stigmosanbromide
- Synstigmini bromidum
- Vagostigmine bromide
- synstigminbromide
- Syntostigmine bromide
- Neostigmina bromuro
- Synthostigmine bromide
- Neostigmine methyl bromide
- Syntostigmin (tablet)
- syntostigminbromide
- vagostigminebromide
- NEOSTIGMINE
- syntostigminebromide
- Vagostigmin (TN)
- synthostigminebromide
- Neostigmine (Bromide)
- Prestwick_352
- syntostigmin(tablet)
- Bromide, Neostigmine
- NEOSTIGMINEBROMIDE
- Prostigmin;Vagostigmin
- RCRA waste number U053
- Neostigmina bromuro [DCIT]
- Neostigmine bromide CRS
- C12H19BrN2O2
- AC1L1QKY
- Opera_ID_1504
- RefChem:832351
- DTXSID9041075
- NEOSTIGIMINE BROMIDE
- 114-80-7 (bromide)
- UNII-005SYP50G5
- AC1Q1RH0
- C12H19N2O2.Br
- MLS000028387
- 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide
- Neostigmini bromidum [INN-Latin]
- 005SYP50G5
- NEO PROSERINE [JAN]
- MFCD00011795
- SCHEMBL41128
- DTXCID7021075
- MLS001146913
- orb342006
- CHEMBL54126
- NSC-757233
- SPECTRUM1500428
- CHEBI:179557
- EINECS 204-054-8
- Bromure de neostigmine [INN-French]
- Bromuro de neostigmina [INN-Spanish]
- Eustigmin bromide;Neoserine bromide
- LCZC2572
- orb2946024
- Neostigmine bromide (Prostigmin)
- NEOSTIGMINE BROMIDE [MI]
- SCHEMBL29618009
- ERK5-1J04
- HMS500I07
- HY-B0423R
- KS-00000YWF
- CID8246
- Neostigmine bromide [INN:BAN:JAN]
- NEOSTIGMINE BROMIDE [INN]
- NEOSTIGMINE BROMIDE [JAN]
- LULNWZDBKTWDGK-UHFFFAOYSA-M
- Neostigmine (Bromide) (Standard)
- HMS1569M18
- HMS1920P15
- HMS2091H18
- HMS2096M18
- HMS2235J11
- HMS3262D13
- HMS3372E02
- HMS3713M18
- Pharmakon1600-01500428
- C12-H19-N2-O2.Br
- NEOSTIGMINE BROMIDE [VANDF]
- ACT05638
- HY-B0423
- MSK10462
- NEOSTIGMINE BROMIDE [MART.]
- Neostigmine bromide (JAN/USP/INN)
- Neostigmine bromide [BAN:INN:JAN]
- Tox21_112037
- Tox21_500816
- 3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide
- AN-333
- AR-1F0755
- CCG-39110
- EBC-04137
- NEOSTIGMINE BROMIDE [USP-RS]
- NEOSTIGMINE BROMIDE [WHO-DD]
- NEOSTIGMINE BROMIDE [WHO-IP]
- NSC757233
- s2490
- Neostigmine bromide [USP:INN:BAN:JAN]
- SMR000058591
- AKOS015895725
- Tox21_112037_1
- (m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamate
- CS-2529
- FN26183
- LP00816
- NSC 757233
- 3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide
- NCGC00015730-11
- NCGC00094149-01
- NCGC00094149-02
- NCGC00094149-03
- NCGC00094149-04
- NCGC00163240-01
- NCGC00261501-01
- AK162162
- BS-14646
- CAS-114-80-7
- DA-66031
- LS-18446
- NEOSTIGMINE BROMIDE [EP MONOGRAPH]
- Q562
- SC-19050
- 3-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic ester
- MLS-0002855.P042
- NEOSTIGMINE BROMIDE [USP MONOGRAPH]
- AB0004770
- AB2000595
- NEOSTIGMINI BROMIDUM [WHO-IP LATIN]
- 114-80-7, 59-99-4 [neostigmine]
- B1594
- EU-0100816
- FT-0651572
- N0358
- NS00079222
- ST24041334
- ST50411544
- [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;bromide
- A10635
- C08197
- C71473
- D00995
- N 2001
- [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium
- 3-(Dimethylcarbamoyloxy)trimethylanilinium ion Bromatum
- A803245
- Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide
- EN300-12576352
- F160100
- SR-01000000073
- A1198860
- SR-01000000073-3
- SR-01000000073-5
- SR-01000000073-7
- (3-Dimethylcarbamoyloxyphenyl)trimethylammonium Bromide
- Q27105147
- (3-(dimethylcarbamoyloxy)phenyl)-trimethylazanium;bromide
- [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide
- Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide
- (m-Hydroxyphenyl)trimethyl-ammonium bromide dimethylcarbamate
- [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium bromide
- [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-ammonium;bromide
- [3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide
- 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium bromide
- N,N-dimethyl[3-(trimethylamino)phenoxy]carboxamide, bromide
- Neostigmine bromide, >=98% (HPLC and titration), powder
- (3-Hydroxyphenyl)trimethylammonium Bromide Dimethyl Carbamate
- [3-[dimethylamino(oxo)methoxy]phenyl]-trimethylammonium bromide
- 3-(N,N-Dimethylcarbamoyloxy)-N,N,N,-trimethylanilinium bromide
- AMMONIUM, (m-HYDROXYPHENYL)TRIMETHYL-, BROMIDE, DIMETHYLCARBAMATE
- Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide
- Neostigmine bromide, European Pharmacopoeia (EP) Reference Standard
- Neostigmine bromide, United States Pharmacopeia (USP) Reference Standard
- Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide (1:1)
- Neostigmine bromide, 98%, a reversible acetylcholinesterase inhibitor - 1G 1g
- 204-054-8
- 61-70-1
- Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide; (m-Hydroxyphenyl)trimethylammonium bromide, dimethylcarbamate; Ammonium, (m-hydroxyphenyl)trimethyl-, bromide, dimethylcarbamate; Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-, bromide; Neostigmine bromide; Carbamic acid, dimethyl-, ester with (m-hydroxyphenyl)trimethylammonium bromide; (3-Dimethylcarbamoyloxyphenyl)trimethylammonium bromide; Eustigmin bromide; Kirkstigmine bromide; Neoeserine bromide; Neoesserin; Philostigmin bromide; Prostigmin bromide; Prostigmine bromide; Stigmanol bromide; Stigmosan bromide; Syntostigmin (tablet); Syntostigmin bromide; Vagostigmine bromide
- N/A